Najat Khan serves as Executive at RECURSION PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Najat Khan has executed 7 insider transactions totaling $750.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 17, 2026 involved selling 14,280 shares valued at $49.8K.
Najat Khan currently holds 2,290,383 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Najat Khan has been a net seller of RXRX stock. They have purchased $0 and sold $750.6K worth of shares.
Najat Khan's most recent insider trade was on Feb 17, 2026, when they sold 14,280 shares at $3.49 per share.
Get notified when new Form 4 filings are submitted
| $4.41 |
| Discretionary |
| Nov 17, 2025 | RXRX | $72.8K | Payment | 17,584 | $4.14 | Discretionary |
| Nov 5, 2025 | RXRX | $0 | Award | 84,925 | $N/A | Discretionary |
| Aug 18, 2025 | RXRX | $202.0K | Sale | 36,599 | $5.52 | Discretionary |
| Aug 15, 2025 | RXRX | $21.4K | Payment | 3,789 | $5.64 | Discretionary |
| Aug 1, 2024 | RXRX | $0 | Award | 496,972 | $N/A | Discretionary |